| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 58822-47-2 | Secoxyloganin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 18842-98-3 | paederosidic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 29836-27-9 | Shanzhiside |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 39011-92-2 | Nuezhenide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 548-37-8 | Verbenalin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 14215-86-2 | Sweroside |
≥98% | | 询价 |
| 7 | 64421-28-9 | Shanzhiside methylester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 117479-87-5 | Sesamoside |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | | Mecillinam-d12 |
≥98% | | 询价 |
| 10 | 405169-16-6 | Dovitinib |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 11 | 1613250-18-2 | Faldaprevir-d7 |
≥98% | | 询价 |
| 12 | 1002345-93-8 | Lovastatin-d3 |
≥98% | | 询价 |
| 13 | | Pitavastatin-d4 hemicalcium |
≥98% | | 询价 |
| 14 | | Elvitegravir-d8 |
≥98% | | 询价 |
| 15 | | Bestatin-d7 HCl |
≥98% | | 询价 |
| 16 | 2738376-78-6 | Amprenavir-d4-1 |
≥98% | | 询价 |
| 17 | 1800462-99-0 | Aminobenzenesulfonic auristatin E |
≥98% | | 询价 |
| 18 | 2738376-83-3 | Cilastatin-15N,d3 |
≥98% | | 询价 |
| 19 | 2732868-49-2 | Topiroxostat-d4 |
≥98% | | 询价 |
| 20 | 2361659-62-1 | GSK8612 |
≥98% | | 询价 |
| 21 | 4376-72-1 | Hexakis(p-bromophenoxy)cyclotriphosphazene |
≥98% | | 询价 |
| 22 | 2089227-65-4 | VBIT-12 |
≥98% | | 询价 |
| 23 | 2250404-95-4 | T-1101 tosylate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 39777-61-2 | TFEB activator 1 |
≥98% | | 询价 |
| 25 | 313520-94-4 | TH-263 |
≥98% | | 询价 |
| 26 | 1898207-64-1 | DS-1001b |
≥98% | | 询价 |
| 27 | 1621673-53-7 | KY-226 |
≥98% | | 询价 |
| 28 | 874146-69-7 | PK11007 |
≥98% | | 询价 |
| 29 | 2088453-21-6 | OATD-01 |
≥98% | | 询价 |
| 30 | 7150-23-4 | JBSNF-000088 |
≥98% | | 询价 |
| 31 | 288383-20-0 | Cediranib |
| 5mg, 10mg, 50mg | 询价 |
| 32 | 838816-57-2 | IN04 |
≥98% | | 询价 |
| 33 | 28718-90-3 | DAPI Dihydrochloride |
≥98% | | 询价 |
| 34 | 58-71-9 | Cefalothin sodium |
≥98% | | 询价 |
| 35 | 439239-92-6 | Lasmiditan succinate(COL144,LY573144) |
≥98% | | 询价 |
| 36 | 303215-67-0 | MitoBloCK-6 |
≥98% | | 询价 |
| 37 | 2639957-39-2 | Exarafenib |
≥98% | | 询价 |
| 38 | 84477-87-2 | Protein kinase inhibitor H-7 |
≥98% | | 询价 |
| 39 | 205254-94-0 | PDGF Receptor Tyrosine Kinase Inhibitor III |
≥98% | | 询价 |
| 40 | 1092847-21-6 | CP-447697 |
≥98% | | 询价 |
| 41 | 533902-29-3 | LCKLSL |
≥98% | | 询价 |
| 42 | 922150-11-6 | SCH529074 |
≥98% | | 询价 |
| 43 | 1421365-63-0 | CYM-50769 |
≥98% | | 询价 |
| 44 | 2351906-74-4 | GA-017 |
≥98% | | 询价 |
| 45 | 757192-67-9 | EN106 |
≥98% | | 询价 |
| 46 | 1259059-71-6 | Bendamustine sulfate |
≥98% | | 询价 |
| 47 | 14252-80-3 | Bupivacaine hydrochloride |
≥98% | | 询价 |
| 48 | 5980-33-6 | Hymecromone sodium |
≥98% | | 询价 |
| 49 | 130952-46-4 | Ozagrel sodium |
≥98% | | 询价 |
| 50 | 17453-58-6 | Bacteriopheophytin a |
≥98% | | 询价 |
| 51 | 69762-85-2 | W-9 HCL |
≥98% | | 询价 |
| 52 | 1201916-31-5 | TCS 2210 |
≥98% | | 询价 |
| 53 | 849461-90-1 | TMPH inhibitor |
≥98% | | 询价 |
| 54 | 2230724-66-8 | BTK inhibitor 27 |
≥98% | | 询价 |
| 55 | 1693734-80-3 | NPX800 |
≥98% | | 询价 |
| 56 | 331859-86-0 | Chromeceptin |
≥98% | | 询价 |
| 57 | 108392-02-5 | DOPA-NA |
≥98% | | 询价 |
| 58 | 2505001-54-5 | SR15006 |
≥98% | | 询价 |
| 59 | 723304-76-5 | CCR8 antagonist 1 |
≥98% | | 询价 |
| 60 | 267654-00-2 | BML-259 |
≥98% | | 询价 |
m.cnreagent.com